FI91763C - Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksiInfo
- Publication number
- FI91763C FI91763C FI885094A FI885094A FI91763C FI 91763 C FI91763 C FI 91763C FI 885094 A FI885094 A FI 885094A FI 885094 A FI885094 A FI 885094A FI 91763 C FI91763 C FI 91763C
- Authority
- FI
- Finland
- Prior art keywords
- fluoropyrimidine
- dideoxy
- preparing
- therapeutically useful
- purine nucleoside
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878726136A GB8726136D0 (en) | 1987-11-07 | 1987-11-07 | Therapeutic nucleosides |
GB8726136 | 1987-11-07 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI885094A0 FI885094A0 (fi) | 1988-11-04 |
FI885094A FI885094A (fi) | 1989-05-08 |
FI91763B FI91763B (fi) | 1994-04-29 |
FI91763C true FI91763C (fi) | 1994-08-10 |
Family
ID=10626612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI885094A FI91763C (fi) | 1987-11-07 | 1988-11-04 | Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi |
Country Status (17)
Country | Link |
---|---|
US (1) | US5574149A (fi) |
EP (3) | EP0317128B1 (fi) |
JP (1) | JP2731551B2 (fi) |
KR (1) | KR890008160A (fi) |
AT (1) | ATE131826T1 (fi) |
AU (1) | AU616914B2 (fi) |
CA (1) | CA1333391C (fi) |
DE (1) | DE3854811T2 (fi) |
DK (1) | DK615788A (fi) |
ES (1) | ES2081286T3 (fi) |
FI (1) | FI91763C (fi) |
GB (1) | GB8726136D0 (fi) |
GR (1) | GR3019379T3 (fi) |
HU (2) | HU204839B (fi) |
MX (1) | MX9203217A (fi) |
PT (1) | PT88948B (fi) |
ZA (1) | ZA888289B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506215A (en) * | 1987-11-03 | 1996-04-09 | Medivir Ab | 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides |
US5157114A (en) * | 1988-08-19 | 1992-10-20 | Burroughs Wellcome Co. | 2',3'-dideoxy-3'-fluoro-5-ethyngluridine |
WO1990003978A1 (en) * | 1988-10-03 | 1990-04-19 | Stichting Rega Vzw | 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application |
WO1991006554A1 (en) * | 1989-11-06 | 1991-05-16 | Nycomed As | Nucleoside derivatives |
FR2668153B1 (fr) * | 1990-10-22 | 1995-03-31 | Pasteur Merieux Serums Vacc | Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant. |
AU3170193A (en) * | 1992-01-06 | 1993-08-03 | Wellcome Foundation Limited, The | Therapeutic nucleosides |
GB9200150D0 (en) * | 1992-01-06 | 1992-02-26 | Wellcome Found | Therapeutic nucleosides |
HU9501978D0 (en) * | 1993-03-31 | 1995-09-28 | Sterling Winthorp Inc | Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
AU6686394A (en) * | 1993-05-12 | 1994-12-12 | Rhone-Poulenc Chemicals Limited | Preparation of fluoro-nucleosides and intermediates for use therein |
PT917879E (pt) * | 1997-11-22 | 2002-12-31 | Roche Diagnostics Gmbh | Processo melhorado para estabilizacao de proteinas |
US6156349A (en) * | 1998-12-14 | 2000-12-05 | Steinbach, Pylant And Herman, L.L.C. | Method of treating HIV infection with suppository containing mammalian liver extract |
US6514979B1 (en) | 1999-03-03 | 2003-02-04 | University Of Maryland Biotechnology Institute | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor |
WO2003000200A2 (en) * | 2001-06-22 | 2003-01-03 | Pharmasset Ltd. | β-2'-OR 3'-HALONUCLEOSIDES |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3328388A (en) * | 1964-09-02 | 1967-06-27 | Merck & Co Inc | Arabinofuranosyl pyrimidines and methods of preparing same |
US3775397A (en) * | 1969-11-12 | 1973-11-27 | Akad Wissenschaften Ddr | Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides |
SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
DD279407A1 (de) * | 1986-07-24 | 1990-06-06 | Akad Wissenschaften Ddr | Verfahren zur herstellung eines mittels gegen aids |
US5153180A (en) * | 1986-07-24 | 1992-10-06 | Eckart Matthes | Fluorinated nucleosides and process for treating retrovirus infections therewith |
GB8719877D0 (en) * | 1987-08-22 | 1987-09-30 | Wellcome Found | Antiviral compounds |
SE8704298D0 (sv) * | 1987-11-03 | 1987-11-03 | Astra Ab | Compounds for use in therapy |
-
1987
- 1987-11-07 GB GB878726136A patent/GB8726136D0/en active Pending
-
1988
- 1988-11-03 EP EP88310344A patent/EP0317128B1/en not_active Expired - Lifetime
- 1988-11-03 AT AT88310344T patent/ATE131826T1/de not_active IP Right Cessation
- 1988-11-03 EP EP95108713A patent/EP0669341A1/en not_active Withdrawn
- 1988-11-03 ES ES88310344T patent/ES2081286T3/es not_active Expired - Lifetime
- 1988-11-03 EP EP95108714A patent/EP0670328A1/en not_active Withdrawn
- 1988-11-03 DE DE3854811T patent/DE3854811T2/de not_active Expired - Fee Related
- 1988-11-04 HU HU902123A patent/HU204839B/hu not_active IP Right Cessation
- 1988-11-04 KR KR1019880014472A patent/KR890008160A/ko not_active Application Discontinuation
- 1988-11-04 CA CA000582322A patent/CA1333391C/en not_active Expired - Fee Related
- 1988-11-04 ZA ZA888289A patent/ZA888289B/xx unknown
- 1988-11-04 HU HU885714A patent/HU200931B/hu not_active IP Right Cessation
- 1988-11-04 PT PT88948A patent/PT88948B/pt not_active IP Right Cessation
- 1988-11-04 FI FI885094A patent/FI91763C/fi not_active IP Right Cessation
- 1988-11-04 AU AU24763/88A patent/AU616914B2/en not_active Ceased
- 1988-11-04 JP JP63279196A patent/JP2731551B2/ja not_active Expired - Lifetime
- 1988-11-04 DK DK615788A patent/DK615788A/da not_active Application Discontinuation
-
1992
- 1992-06-24 MX MX9203217A patent/MX9203217A/es unknown
-
1993
- 1993-05-17 US US08/062,591 patent/US5574149A/en not_active Expired - Fee Related
-
1996
- 1996-03-20 GR GR960400779T patent/GR3019379T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK615788A (da) | 1989-05-08 |
ATE131826T1 (de) | 1996-01-15 |
EP0317128B1 (en) | 1995-12-20 |
DK615788D0 (da) | 1988-11-04 |
ES2081286T3 (es) | 1996-03-01 |
FI885094A0 (fi) | 1988-11-04 |
ZA888289B (en) | 1990-07-25 |
JPH01153697A (ja) | 1989-06-15 |
EP0669341A1 (en) | 1995-08-30 |
AU2476388A (en) | 1989-05-25 |
US5574149A (en) | 1996-11-12 |
MX9203217A (es) | 1992-07-01 |
PT88948A (pt) | 1988-12-01 |
HU200931B (en) | 1990-09-28 |
EP0670328A1 (en) | 1995-09-06 |
GB8726136D0 (en) | 1987-12-09 |
FI91763B (fi) | 1994-04-29 |
HU902123D0 (en) | 1990-07-28 |
DE3854811T2 (de) | 1996-08-01 |
DE3854811D1 (de) | 1996-02-01 |
HUT48466A (en) | 1989-06-28 |
HU204839B (en) | 1992-02-28 |
GR3019379T3 (en) | 1996-06-30 |
EP0317128A3 (en) | 1991-10-02 |
AU616914B2 (en) | 1991-11-14 |
FI885094A (fi) | 1989-05-08 |
PT88948B (pt) | 1993-02-26 |
KR890008160A (ko) | 1989-07-10 |
JP2731551B2 (ja) | 1998-03-25 |
EP0317128A2 (en) | 1989-05-24 |
CA1333391C (en) | 1994-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY102693A (en) | Antiviral nucleosides | |
MY121839A (en) | Antiviral purine derivatives | |
FI101793B1 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 9-purinyylifosfonihappojohdannaisten valmistamiseksi | |
FI91763C (fi) | Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi | |
DE3854297T2 (de) | Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung. | |
CA2215190A1 (en) | Aryl-ester phosphoramidate derivatives of nucleosides | |
AU4690989A (en) | Antiviral cytosine and guanine derivatives | |
FI885153A0 (fi) | Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi | |
WO1993017651A3 (de) | Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung | |
TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
ES8707971A1 (es) | Un metodo para producir un nucleosido de citosina | |
NO932287D0 (no) | 2'-deoksy-2',2'-difluor(2,6,8-substituerte) purine nukleosider med antiviral- og anticanceraktivitet, og mellomprodukter | |
ZA892284B (en) | Novel fluorophosphonate nucleotide derivatives | |
EP0340778A3 (en) | Prodrugs of 2',3'- didehydro-2',3'-dideoxynucleosides | |
EP0335770A3 (en) | Novel fluorophosphonate nucleotide derivatives | |
JPS6422853A (en) | Nucleoside analog | |
HK1009451A1 (en) | Process for the synthesis of nucleoside analogues | |
FI970666A (fi) | Välituotteita ja menetelmiä niiden valmistamiseksi | |
EP0353268A4 (en) | ANTI-TUMOR PURINES OF 6-SULFENAMIDE, 6-SULFINAMIDE AND 6-SULFONAMIDE, PURINE NUCLEOSIDES, PURINE NUCLEOTIDES AND RELATED COMPOUNDS. | |
GEP20002030B (en) | Diastereoselective Synthesis of Nucleosides | |
JPS6426594A (en) | Nucleotides and antitumor agent | |
ES2002342A6 (es) | Procedimiento para la preparacion de 3'-azido-nucleosidos | |
FR2406446A1 (fr) | Application therapeutique de la (s) et (rs)-9-(2,3-dihydroxypropyl)adenine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: THE WELLCOME FOUNDATION LIMITED |